Intellectus Partners, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Intellectus Partners, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$547,267
-35.2%
120,279
+0.2%
0.17%
-31.9%
Q2 2023$845,001
+27.0%
120,029
+10.2%
0.25%
+21.0%
Q1 2023$665,248
+18.8%
108,879
+24.2%
0.21%
+7.7%
Q4 2022$560,084
+27.3%
87,650
+90.6%
0.20%
+25.0%
Q3 2022$440,000
-13.4%
45,9770.0%0.16%
-10.9%
Q2 2022$508,000
-18.8%
45,977
+22.3%
0.18%
-6.4%
Q1 2022$626,000
-18.3%
37,600
-6.2%
0.19%
-4.1%
Q4 2021$766,000
-47.2%
40,100
-31.8%
0.20%
-44.4%
Q3 2021$1,450,000
-4.0%
58,800
+1.3%
0.35%
+3.2%
Q2 2021$1,510,000
+12.1%
58,050
+36.4%
0.34%
-8.1%
Q1 2021$1,347,000
-30.2%
42,550
+2.3%
0.37%
-36.0%
Q4 2020$1,930,000
+68.7%
41,600
+19.7%
0.58%
+33.8%
Q3 2020$1,144,000
+40.2%
34,750
+16.9%
0.43%
+36.7%
Q2 2020$816,000
+130.5%
29,735
+151.2%
0.32%
+87.0%
Q1 2020$354,000
+46.3%
11,835
+35.5%
0.17%
+72.4%
Q4 2019$242,0008,7350.10%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MHR Fund Management 11,997,103$84,459,60511.88%
MPM BioImpact LLC 2,950,118$20,768,8314.18%
Perceptive Advisors 14,036,410$98,816,3262.86%
Velan Capital Investment Management LP 240,000$1,689,6001.57%
Parametrica Management Ltd 96,500$679,3601.31%
Boxer Capital, LLC 3,705,133$26,0841.21%
Soleus Capital Management, L.P. 1,239,777$8,728,0300.97%
Opaleye Management Inc. 421,000$2,963,8400.71%
683 Capital Management, LLC 1,400,000$9,856,0000.71%
RICE HALL JAMES & ASSOCIATES, LLC 1,758,759$12,381,6650.70%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders